IS5543A - Nýr G próteintengdur viðtaki - Google Patents

Nýr G próteintengdur viðtaki

Info

Publication number
IS5543A
IS5543A IS5543A IS5543A IS5543A IS 5543 A IS5543 A IS 5543A IS 5543 A IS5543 A IS 5543A IS 5543 A IS5543 A IS 5543A IS 5543 A IS5543 A IS 5543A
Authority
IS
Iceland
Prior art keywords
protein
new
coupled receptor
directed
present
Prior art date
Application number
IS5543A
Other languages
English (en)
Inventor
Ahmad Sultan
O'donell Dajan
Lembo Paola
Banville Denis
Fortin Yves
Shen Shi-Hsiang
Original Assignee
Astrazeneca Canada Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Canada Inc. filed Critical Astrazeneca Canada Inc.
Publication of IS5543A publication Critical patent/IS5543A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IS5543A 1997-12-22 2000-06-21 Nýr G próteintengdur viðtaki IS5543A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704836A SE9704836D0 (sv) 1997-12-22 1997-12-22 Novel receptor
PCT/SE1998/002348 WO1999032519A1 (en) 1997-12-22 1998-12-16 Novel g protein-coupled receptor

Publications (1)

Publication Number Publication Date
IS5543A true IS5543A (is) 2000-06-21

Family

ID=20409539

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5543A IS5543A (is) 1997-12-22 2000-06-21 Nýr G próteintengdur viðtaki

Country Status (19)

Country Link
US (3) US6696257B1 (is)
EP (1) EP1051434B1 (is)
JP (1) JP2001526064A (is)
KR (1) KR20010033486A (is)
CN (1) CN1284966A (is)
AT (1) ATE325132T1 (is)
AU (1) AU756861B2 (is)
BR (1) BR9814335A (is)
CA (1) CA2316280C (is)
DE (1) DE69834432T2 (is)
ES (1) ES2262252T3 (is)
IL (1) IL136728A0 (is)
IS (1) IS5543A (is)
NO (1) NO20003221L (is)
PL (1) PL341524A1 (is)
SE (1) SE9704836D0 (is)
SK (1) SK8752000A3 (is)
TR (1) TR200001861T2 (is)
WO (1) WO1999032519A1 (is)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
CA2344459A1 (en) * 1998-10-01 2000-04-13 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
AU774850B2 (en) * 1999-01-04 2004-07-08 Lexicon Pharmaceuticals, Inc. Human seven-transmembrane receptors
IL149569A0 (en) * 1999-11-17 2002-11-10 Arena Pharm Inc Endogenous and non-endogenous versions of human g protein-coupled receptors
EP1242454A2 (en) * 1999-12-28 2002-09-25 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
AU5473201A (en) * 2000-03-24 2001-10-03 Bayer Aktiengesellschaft Regulation of human mas oncogene-related g protein-coupled receptor
CA2404563A1 (en) * 2000-03-27 2001-10-04 Pe Corporation (Ny) Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
WO2001072838A2 (en) * 2000-03-29 2001-10-04 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
GB0008252D0 (en) * 2000-04-04 2000-05-24 Janssen Pharmaceutica Nv G protien coupled receptor
EP1303601A2 (en) * 2000-04-06 2003-04-23 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
AU2001253771A1 (en) * 2000-04-24 2001-11-07 Pe Corporation (Ny) Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
US7691604B1 (en) 2000-05-04 2010-04-06 California Institute Of Technology MRG polypeptides and nucleic acids encoding the same
US7510845B2 (en) * 2000-05-04 2009-03-31 California Institute Of Technology Assay employing G protein-coupled receptor expressed in dorsal root ganglia
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
WO2001083555A2 (en) * 2000-05-04 2001-11-08 California Institute Of Technology Pain signaling molecules
CA2413435A1 (en) * 2000-06-20 2001-12-27 Euroscreen S.A. A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists
US20020198368A1 (en) * 2000-08-02 2002-12-26 Gabriel Vogeli Novel G protein-coupled receptors
CA2354253A1 (en) * 2000-08-04 2002-02-04 Switch Biotech Ag Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances
US20030148281A1 (en) * 2000-10-05 2003-08-07 Glucksmann Maria A. 65499 and 58875, novel seven transmembrane receptors and uses thereof
AU2001296150A1 (en) 2000-10-17 2002-04-29 Astrazeneca Ab Assays
US20040076951A1 (en) * 2000-10-25 2004-04-22 Ming-Hui Wei Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
EP1343006A4 (en) * 2000-11-15 2007-06-06 Akiko Itai PROCESS FOR CHARACTERIZING PROTEINS
CA2430719A1 (en) 2000-12-22 2002-07-04 Astrazeneca Ab A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor
EP1360294A2 (en) * 2001-02-08 2003-11-12 Bayer Aktiengesellschaft Regulation of human dorsal root receptor-like g protein-coupled receptor
DK1399744T3 (da) * 2001-06-27 2008-09-22 Janssen Pharmaceutica Nv EPF-receptorassays, forbindelser og terapeutiske præparater
EP1424557A4 (en) * 2001-09-03 2007-12-26 Takeda Pharmaceutical USE OF A G-PROTEIN-COUPLED RECEPTOR PROTEIN
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
AU2003221878A1 (en) 2002-04-12 2003-10-27 Schering Corporation G-protein coupled receptor ligands and methods
US20040121410A1 (en) * 2002-12-20 2004-06-24 Anderson David J. Pain signaling molecules
WO2004111642A2 (en) * 2003-06-16 2004-12-23 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 1 (snsr1)
WO2005003762A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 2 (snsr2)
WO2005003780A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 4 (snsr4)
WO2005003779A2 (en) * 2003-06-17 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with sensory neuron-specific g protein-coupled receptor 3 (snsr3)
WO2005003763A2 (en) * 2003-06-18 2005-01-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with mas related g-protein coupled receptor 3 (mrgx3)
EP2571989A4 (en) 2010-05-18 2014-08-13 Univ Mcgill METHOD FOR REDUCING THE EXPRESSION OF SPICY GLIOMES FROM DOWN REGULATED KIDNEY CELL CARCINOMES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4855393A (en) 1992-09-10 1994-03-29 New York University Polypeptides of g-coupled receptor proteins, and compositions and methods thereof
US5556780A (en) * 1993-07-30 1996-09-17 The Board Of Trustees For The Leland Stanford Junior University CDNAS encoding mouse and rat type-2 angiotensin II receptors and their expression in host cells

Also Published As

Publication number Publication date
AU1990499A (en) 1999-07-12
JP2001526064A (ja) 2001-12-18
CN1284966A (zh) 2001-02-21
EP1051434A1 (en) 2000-11-15
PL341524A1 (en) 2001-04-23
US7217693B2 (en) 2007-05-15
US6696257B1 (en) 2004-02-24
KR20010033486A (ko) 2001-04-25
CA2316280C (en) 2010-07-13
AU756861B2 (en) 2003-01-23
EP1051434B1 (en) 2006-05-03
IL136728A0 (en) 2001-06-14
ATE325132T1 (de) 2006-06-15
TR200001861T2 (tr) 2000-11-21
BR9814335A (pt) 2000-10-10
WO1999032519A1 (en) 1999-07-01
SK8752000A3 (en) 2001-01-18
CA2316280A1 (en) 1999-07-01
NO20003221L (no) 2000-08-10
NO20003221D0 (no) 2000-06-21
WO1999032519A9 (en) 1999-09-30
DE69834432D1 (de) 2006-06-08
DE69834432T2 (de) 2007-04-12
US20060068466A1 (en) 2006-03-30
SE9704836D0 (sv) 1997-12-22
ES2262252T3 (es) 2006-11-16
US20090226932A1 (en) 2009-09-10

Similar Documents

Publication Publication Date Title
SE9704836D0 (sv) Novel receptor
ATE377606T1 (de) Zyklische antagonisten der c5a rezeptoren sowie der g-protein gekoppelten rezeptoren
EA200300441A1 (ru) Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения
BR0113921A (pt) ácidos nucléicos e polipeptìdeos receptores
EA199901013A1 (ru) Гели пролонгированного действия
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
IL142103A0 (en) Receptor based antagonists and methods of making and using
ATE387461T1 (de) Neuer g-protein-gekoppelter rezeptor
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
MX9801987A (es) Nuevos derivados de aminoacido, su obtencion y su uso.
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
EA200000086A1 (ru) Алатрофлоксациновые парентеральные составы
EP1147123A4 (en) INNOVATIVE ODOR RECEPTORS IN DROSOPHILA
ATE312919T1 (de) Schmerz signalisierende moleküle
EP1456239A4 (en) HYBRID PROTEINS FACED WITH HEPARANSULFATE PROTEOGLYCANE WITH NEUREGULIN-HEPARIN BINDING DOMAIN
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
SE9804274D0 (sv) Novel receptor
SE9902763D0 (sv) Novel receptor
ATE511644T1 (de) Neues screening-verfahren
EA200100299A1 (ru) Уреидопиперидиновые производные как селективные антагонисты nk3 - рецепторов человека
EA200400764A1 (ru) 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение